PARIS, FRANCE, March 12th, 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today the appointment…
DAVIS, Calif., March 11, 2025 /PRNewswire/ -- openRxiv has officially launched as an independent nonprofit to oversee bioRxiv and medRxiv,…
Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year…
CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the…
Topline data expected in second half of 2025 to support potential sNDA submission for label expansion of IGALMI® in the home…
Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience PHILADELPHIA, March 10,…
Introducing "21 Days of Restful Sleep with Dr. Deepak Chopra & Elemind"—A New Ritual Combining Guided Meditations and Pioneering Wearable…
Introducing "21 Days of Restful Sleep with Dr. Deepak Chopra & Elemind"—A New Ritual Combining Guided Meditations and Pioneering Wearable…
PORTLAND, Maine, March 6, 2025 /PRNewswire/ -- MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation…
A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment…
